ea0059p218 | Thyroid | SFEBES2018
Aljenaee Khaled
, McDonnell Tara
, Cooke Jennie
, Phelan Niamh
, Pazderska Agnieszka
, Healy Marie-Loiuse
Background: Radioiodine (RAI) is widely used for the treatment of hyperthyroidism. Most patients respond to RAI therapy with a normalization of TFTs and improvement in clinical symptoms within 48 weeks. Hypothyroidism may occur from 4 weeks on, with 40% of patients being hypothyroid by 8 weeks and >80% by 16 weeks. American thyroid association guidelines recommend testing for free T4, total T3, and TSH within the first 12 months after RAI. Biochemical monitorin...